NCT03489772View on ClinicalTrials.gov

Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

ITI-214

Oral

DRUG

Placebo

Oral

Trial Locations (1)

74136

Laureate Institute for Brain Research, Inc., Tulsa

Sponsors
All Listed Sponsors
collaborator

Laureate Institute for Brain Research, Inc.

OTHER

lead

Intra-Cellular Therapies, Inc.

INDUSTRY